Literature DB >> 28815879

Calibrated imaging reveals altered grey matter metabolism related to white matter microstructure and symptom severity in multiple sclerosis.

Nicholas A Hubbard1, Monroe P Turner2, Minhui Ouyang3,4, Lyndahl Himes2, Binu P Thomas2,5, Joanna L Hutchison2, Shawheen Faghihahmadabadi6, Scott L Davis7, Jeremy F Strain8, Jeffrey Spence2, Daniel C Krawczyk2,9, Hao Huang3,4, Hanzhang Lu10, John Hart2,11, Teresa C Frohman12, Elliot M Frohman12, Darin T Okuda11, Bart Rypma2,9.   

Abstract

Multiple sclerosis (MS) involves damage to white matter microstructures. This damage has been related to grey matter function as measured by standard, physiologically-nonspecific neuroimaging indices (i.e., blood-oxygen-level dependent signal [BOLD]). Here, we used calibrated functional magnetic resonance imaging and diffusion tensor imaging to examine the extent to which specific, evoked grey matter physiological processes were associated with white matter diffusion in MS. Evoked changes in BOLD, cerebral blood flow (CBF), and oxygen metabolism (CMRO2 ) were measured in visual cortex. Individual differences in the diffusion tensor measure, radial diffusivity, within occipital tracts were strongly associated with MS patients' BOLD and CMRO2 . However, these relationships were in opposite directions, complicating the interpretation of the relationship between BOLD and white matter microstructural damage in MS. CMRO2 was strongly associated with individual differences in patients' fatigue and neurological disability, suggesting that alterations to evoked oxygen metabolic processes may be taken as a marker for primary symptoms of MS. This work demonstrates the first application of calibrated and diffusion imaging together and details the first application of calibrated functional MRI in a neurological population. Results lend support for neuroenergetic hypotheses of MS pathophysiology and provide an initial demonstration of the utility of evoked oxygen metabolism signals for neurology research. Hum Brain Mapp 38:5375-5390, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  blood flow and metabolism; calibrated imaging; diffusion tensor imaging; multiple sclerosis; white matter

Mesh:

Substances:

Year:  2017        PMID: 28815879      PMCID: PMC5877313          DOI: 10.1002/hbm.23727

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  96 in total

1.  Reproducibility of BOLD, perfusion, and CMRO2 measurements with calibrated-BOLD fMRI.

Authors:  Oleg Leontiev; Richard B Buxton
Journal:  Neuroimage       Date:  2007-01-05       Impact factor: 6.556

2.  Cerebral blood flow and BOLD responses to a memory encoding task: a comparison between healthy young and elderly adults.

Authors:  Khaled Restom; Katherine J Bangen; Mark W Bondi; Joanna E Perthen; Thomas T Liu
Journal:  Neuroimage       Date:  2007-05-25       Impact factor: 6.556

3.  Quantitative functional imaging of the brain: towards mapping neuronal activity by BOLD fMRI.

Authors:  F Hyder; I Kida; K L Behar; R P Kennan; P K Maciejewski; D L Rothman
Journal:  NMR Biomed       Date:  2001 Nov-Dec       Impact factor: 4.044

4.  Quality of life in multiple sclerosis: the impact of depression, fatigue and disability.

Authors:  M P Amato; G Ponziani; F Rossi; C L Liedl; C Stefanile; L Rossi
Journal:  Mult Scler       Date:  2001-10       Impact factor: 6.312

5.  Searching for a truly "iso-metabolic" gas challenge in physiological MRI.

Authors:  Shin-Lei Peng; Harshan Ravi; Min Sheng; Binu P Thomas; Hanzhang Lu
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

Review 6.  The neuro-ophthalmology of multiple sclerosis.

Authors:  Elliot M Frohman; Teresa C Frohman; David S Zee; Roderick McColl; Steven Galetta
Journal:  Lancet Neurol       Date:  2005-02       Impact factor: 44.182

7.  The efficiency of fMRI region of interest analysis methods for detecting group differences.

Authors:  Joanna L Hutchison; Nicholas A Hubbard; Ryan M Brigante; Monroe Turner; Traci I Sandoval; G Andrew J Hillis; Travis Weaver; Bart Rypma
Journal:  J Neurosci Methods       Date:  2014-01-30       Impact factor: 2.390

8.  Quantifying degeneration of white matter in normal aging using fractal dimension.

Authors:  Luduan Zhang; David Dean; Jing Z Liu; Vinod Sahgal; Xiaofeng Wang; Guang H Yue
Journal:  Neurobiol Aging       Date:  2006-07-24       Impact factor: 4.673

Review 9.  Multiple sclerosis: an immune or neurodegenerative disorder?

Authors:  Bruce D Trapp; Klaus-Armin Nave
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

10.  Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis.

Authors:  Sarah Cader; Alberto Cifelli; Yasir Abu-Omar; Jacqueline Palace; Paul M Matthews
Journal:  Brain       Date:  2005-10-26       Impact factor: 13.501

View more
  4 in total

1.  Altered task-induced cerebral blood flow and oxygen metabolism underlies motor impairment in multiple sclerosis.

Authors:  Kathryn L West; Dinesh K Sivakolundu; Mark D Zuppichini; Monroe P Turner; Jeffrey S Spence; Hanzhang Lu; Darin T Okuda; Bart Rypma
Journal:  J Cereb Blood Flow Metab       Date:  2020-03-03       Impact factor: 6.200

2.  Cerebrovascular Reactivity and Neurovascular Coupling in Multiple Sclerosis-A Systematic Review.

Authors:  Mark B Vestergaard; Jette L Frederiksen; Henrik B W Larsson; Stig P Cramer
Journal:  Front Neurol       Date:  2022-06-01       Impact factor: 4.086

3.  Preserved canonicality of the BOLD hemodynamic response reflects healthy cognition: Insights into the healthy brain through the window of Multiple Sclerosis.

Authors:  Monroe P Turner; Nicholas A Hubbard; Dinesh K Sivakolundu; Lyndahl M Himes; Joanna L Hutchison; John Hart; Jeffrey S Spence; Elliot M Frohman; Teresa C Frohman; Darin T Okuda; Bart Rypma
Journal:  Neuroimage       Date:  2018-02-15       Impact factor: 6.556

4.  Resting cerebral oxygen metabolism exhibits archetypal network features.

Authors:  Nicholas A Hubbard; Monroe P Turner; Kevin R Sitek; Kathryn L West; Jakub R Kaczmarzyk; Lyndahl Himes; Binu P Thomas; Hanzhang Lu; Bart Rypma
Journal:  Hum Brain Mapp       Date:  2021-02-05       Impact factor: 5.399

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.